Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gregory Q Del Prete

Showing results (51-60 of 58) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 58 results.
The Journal of Clinical Investigation|January 19, 2021
Antibody-mediated depletion of viral reservoirs is limited in SIV-infected macaques treated early with antiretroviral therapyAdrienne E Swanstrom, Taina T Immonen, Kelli Oswald, et al.
The Journal of Clinical Investigation|March 1, 2022
Interleukin-10 contributes to reservoir establishment and persistence in SIV-infected macaques treated with antiretroviral therapyJustin Harper, Susan P Ribeiro, Chi Ngai Chan, et al.
Plos Pathogens|September 5, 2018
HLA-C downregulation by HIV-1 adapts to host HLA genotypeNathaniel D Bachtel, Gisele Umviligihozo, Suzanne Pickering, et al.
JCI Insight|June 7, 2019
TLR7 agonist administration to SIV-infected macaques receiving early initiated cART does not induce plasma viremiaGregory Q Del Prete, W Gregory Alvord, Yuan Li, et al.
Science (New York, N.Y.)|January 6, 2018
Elevated <i>HLA-A</i> expression impairs HIV control through inhibition of NKG2A-expressing cellsVeron Ramsuran, Vivek Naranbhai, Amir Horowitz, et al.
Nature|July 22, 2014
Type I interferon responses in rhesus macaques prevent SIV infection and slow disease progressionNetanya G Sandler, Steven E Bosinger, Jacob D Estes, et al.
Cell Host & Microbe|July 12, 2019
The Landscape of Persistent Viral Genomes in ART-Treated SIV, SHIV, and HIV-2 InfectionsAlexandra M Bender, Francesco R Simonetti, Mithra R Kumar, et al.
Nature Medicine|October 3, 2017
Defining total-body AIDS-virus burden with implications for curative strategiesJacob D Estes, Cissy Kityo, Francis Ssali, et al.
Pageof 6

Showing results (51-60 of 58) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 58 results.
The Journal of Clinical Investigation|January 19, 2021
Antibody-mediated depletion of viral reservoirs is limited in SIV-infected macaques treated early with antiretroviral therapyAdrienne E Swanstrom, Taina T Immonen, Kelli Oswald, et al.
The Journal of Clinical Investigation|March 1, 2022
Interleukin-10 contributes to reservoir establishment and persistence in SIV-infected macaques treated with antiretroviral therapyJustin Harper, Susan P Ribeiro, Chi Ngai Chan, et al.
Plos Pathogens|September 5, 2018
HLA-C downregulation by HIV-1 adapts to host HLA genotypeNathaniel D Bachtel, Gisele Umviligihozo, Suzanne Pickering, et al.
JCI Insight|June 7, 2019
TLR7 agonist administration to SIV-infected macaques receiving early initiated cART does not induce plasma viremiaGregory Q Del Prete, W Gregory Alvord, Yuan Li, et al.
Science (New York, N.Y.)|January 6, 2018
Elevated <i>HLA-A</i> expression impairs HIV control through inhibition of NKG2A-expressing cellsVeron Ramsuran, Vivek Naranbhai, Amir Horowitz, et al.
Nature|July 22, 2014
Type I interferon responses in rhesus macaques prevent SIV infection and slow disease progressionNetanya G Sandler, Steven E Bosinger, Jacob D Estes, et al.
Cell Host & Microbe|July 12, 2019
The Landscape of Persistent Viral Genomes in ART-Treated SIV, SHIV, and HIV-2 InfectionsAlexandra M Bender, Francesco R Simonetti, Mithra R Kumar, et al.
Nature Medicine|October 3, 2017
Defining total-body AIDS-virus burden with implications for curative strategiesJacob D Estes, Cissy Kityo, Francis Ssali, et al.
Pageof 6